Basic Information
| LncRNA/CircRNA Name | ENST00000539653 |
| Synonyms | ENS-653 |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | papillary thyroid cancer |
| ICD-0-3 | NA |
| Methods | qPCR, Western blot, RNA-seq, Microarray |
| Sample | PTC tissues,cell line(IHH4) |
| Expression Pattern | up-regulated |
| Function Description | the role of lncRNA ENST00000539653.1 (ENS-653), which was significantly upregulated in PTC versus adjacent normal tissues (P????.01). |
| Pubmed ID | 30940124 |
| Year | 2019 |
| Title | LncRNA ENST00000539653 acts as an oncogenic factor via MAPK signalling in papillary thyroid cancer. |
External Links
| Links for ENST00000539653 | GenBank HGNC NONCODE |
| Links for papillary thyroid cancer | OMIM COSMIC |